This country profile provides an overview of Angola’s progress in reaching those in need of mass NTD treatment based on 2016 data.

NTD mass treatment coverage index: 7/100
Overall rank: 32nd

Treatment coverage

Lymphatic filariasis
1%
Onchocerciasis
2%
Schistosomiasis
50%
STH
26%
Trachoma
?
3.1m people received treatment in Angola in 2016 11.4m people in need did not receive treatment in Angola in 2016

The ESPEN portal (a World Health Organization AFRO region project) provides maps and district-level data for the preventive chemotherapy diseases in Angola.

Angola recommendations

These recommendations were given to heads of state at the African Union summit in January 2017 as part of the ALMA Scorecard for Accountability and Action.

  • Given the good schistosomiasis preventive chemotherapy coverage (PC) already achieved, work to improve the co-implementation of PC for lymphatic filariasis and soil-transmitted helminths and begin treatment with albendazole twice a year in lymphatic filariasis endemic districts and commit to onchocerciasis elimination.
  • Increase budget allocation for neglected tropical diseases at the national level.
  • Provide timely data to the Expanded Special Project for Elimination of Neglected Tropical Diseases (ESPEN) to enable monitoring and planning.

Lymphatic filariasis

⬆ Treatment coverage slightly increased from 0% in 2015 to 1% in 2016.

People needing treatment
5.35m
People receiving treatment
0 reported

Onchocerciasis

⬆ Treatment coverage slightly increased from 0% in 2015 to 2% in 2016.

People needing treatment
5.55m
People receiving treatment
124,000

Schistosomiasis

⬆ Treatment coverage increased from 14% in 2015 to 50% in 2016.

School-aged children needing treatment
3.28m
School-aged children receiving treatment
1.64m

Soil-transmitted helminths

⬆ Treatment coverage increased from 12% in 2015 to 26% in 2016.

Pre-sch and school-aged children needing treatment
11.2m
Pre-school and school-aged children receiving treatment
2.97m

Trachoma

Angola may require interventions for trachoma, investigation needed.